Latest News about FDA
Recent news which mentions FDA
From Benzinga
From Benzinga
Over 400 Physicians And Medical Experts Demand U.S. Gov Fully Deschedule Cannabis, Citing Insufficiency Of Rescheduling
June 13, 2024
Tickers
NEWS
From Benzinga
From Benzinga
From Benzinga
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
June 07, 2024
From Benzinga
Some Breather For E-Cigarette Maker Juul As FDA Reconsiders Marketing Denials Issued Two Years Ago
June 06, 2024
From Benzinga
Eli Lilly's Alzheimer's Drug, Donanemab Faces FDA's Adcomm Vote Next Week On Data, Risk Profile
June 06, 2024
From Benzinga
FDA Committee 'Completely Lost Sight Of The Big Picture' Says Retired Lieutenant General Urging Approval On MDMA For PTSD
June 06, 2024
From Benzinga
From Benzinga
Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
June 05, 2024
From Benzinga
From Benzinga
From Benzinga
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates
June 04, 2024
Tickers
NEWS
From Benzinga
MDMA Therapy For PTSD Closer To Legality As Key FDA Approval Meeting Approaches, Sparking Hope And Controversy
June 03, 2024
Tickers
NEWS
From Benzinga
Why Microbot Medical Stock Is Up
June 03, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.